O'Rourke J - Search Results

1

Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review.

O'Rourke J, Townsend CL, Milanzi E, Collins IJ, Castro H, Judd A, Vicari M, Jesson J, Leroy V, Penazzato M, Renaud F. O'Rourke J, et al. J Int AIDS Soc. 2023 Feb;26(2):e26037. doi: 10.1002/jia2.26037. J Int AIDS Soc. 2023. PMID: 36823283 Free PMC article. Review.

2

Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review.

Saint-Lary L, Dassi Tchoupa Revegue MH, Jesson J, Renaud F, Penazzato M, Townsend CL, O'Rourke J, Leroy V; WHO HIV Hepatitis and STIs (HHS) Department. Saint-Lary L, et al. Front Pediatr. 2022 May 23;10:913105. doi: 10.3389/fped.2022.913105. eCollection 2022. Front Pediatr. 2022. PMID: 35676899 Free PMC article.

3

Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis.

Jesson J, Saint-Lary L, Revegue MHDT, O'Rourke J, Townsend CL, Renaud F, Penazzato M, Leroy V. Jesson J, et al. Lancet Child Adolesc Health. 2022 Oct;6(10):692-704. doi: 10.1016/S2352-4642(22)00213-9. Epub 2022 Sep 2. Lancet Child Adolesc Health. 2022. PMID: 36058225 Free PMC article.

4

Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review.

Townsend CL, O'Rourke J, Milanzi E, Collins IJ, Judd A, Castro H, Vicari M, Jesson J, Leroy V, Renaud F, Penazzato M. Townsend CL, et al. J Int AIDS Soc. 2022 Nov;25(11):e25970. doi: 10.1002/jia2.25970. J Int AIDS Soc. 2022. PMID: 36377082 Free PMC article. Review.

5

Effectiveness of testing, contact tracing and isolation interventions among the general population on reducing transmission of SARS-CoV-2: a systematic review.

Littlecott H, Herd C, O'Rourke J, Chaparro LT, Keeling M, James Rubin G, Fearon E. Littlecott H, et al. Philos Trans A Math Phys Eng Sci. 2023 Oct 9;381(2257):20230131. doi: 10.1098/rsta.2023.0131. Epub 2023 Aug 23. Philos Trans A Math Phys Eng Sci. 2023. PMID: 37611628 Free PMC article.

6

Systematic literature review of the global burden of illness of mantle cell lymphoma.

Monga N, Garside J, Quigley J, Hudson M, O'Donovan P, O'Rourke J, Tapprich C, Parisi L, Davids MS, Tam C. Monga N, et al. Curr Med Res Opin. 2020 May;36(5):843-852. doi: 10.1080/03007995.2020.1742101. Epub 2020 Mar 31. Curr Med Res Opin. 2020. PMID: 32162977

7

Soybean genomics research community strategic plan: A vision for 2024-2028.

Stupar RM, Locke AM, Allen DK, Stacey MG, Ma J, Weiss J, Nelson RT, Hudson ME, Joshi T, Li Z, Song Q, Jedlicka JR, MacIntosh GC, Grant D, Parrott WA, Clemente TE, Stacey G, An YC, Aponte-Rivera J, Bhattacharyya MK, Baxter I, Bilyeu KD, Campbell JD, Cannon SB, Clough SJ, Curtin SJ, Diers BW, Dorrance AE, Gillman JD, Graef GL, Hancock CN, Hudson KA, Hyten DL, Kachroo A, Koebernick J, Libault M, Lorenz AJ, Mahan AL, Massman JM, McGinn M, Meksem K, Okamuro JK, Pedley KF, Rainey KM, Scaboo AM, Schmutz J, Song BH, Steinbrenner AD, Stewart-Brown BB, Toth K, Wang D, Weaver L, Zhang B, Graham MA, O'Rourke JA. Stupar RM, et al. Among authors: o rourke ja. Plant Genome. 2024 Nov 21:e20516. doi: 10.1002/tpg2.20516. Online ahead of print. Plant Genome. 2024. PMID: 39572930 Free article.

8

Investigating the Role of Known Arabidopsis Iron Genes in a Stress Resilient Soybean Line.

O'Rourke JA, Graham MA. O'Rourke JA, et al. Int J Mol Sci. 2024 Oct 25;25(21):11480. doi: 10.3390/ijms252111480. Int J Mol Sci. 2024. PMID: 39519033 Free PMC article.

9

A study of the enablers and barriers to the collection of sociodemographic data by public health units in Ontario, Canada during the COVID-19 pandemic.

Komeiha M, Kujbida G, Reynolds A, Mbagwu I, Dojeiji L, O'Rourke JJ, Raju S, Varia M, Stylianou H, Burgess S, Ogundele OJ, Pinto AD. Komeiha M, et al. Among authors: o rourke jj. BMC Public Health. 2024 Nov 6;24(1):3061. doi: 10.1186/s12889-024-20519-4. BMC Public Health. 2024. PMID: 39506709 Free PMC article.

10

TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer.

Marwedel B, De May H, Anderson L, Medina LY, Kennedy E, Flores E, O'Rourke J, Olewine M, Lagutina I, Fitzpatrick L, Shultz F, Kusewitt DF, Bartee E, Adams S, Noureddine A, Serda RE. Marwedel B, et al. Among authors: o rourke j. Adv Healthc Mater. 2024 Oct 31:e2402966. doi: 10.1002/adhm.202402966. Online ahead of print. Adv Healthc Mater. 2024. PMID: 39478634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters